660
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Potentiation of Immune Response from Polymer-Entrapped Antigen: Toward Development of Single Dose Tetanus Toxoid Vaccine

, , , &
Pages 231-238 | Published online: 31 Jan 2011

REFERENCES

  • Alonso, M. J., Gupta, R. K., Min, C., Siberia, G .R., and Langer, R. 1994. Biodegradable microspheres as controlled-release tetanus toxoid delivery sys- tems. Vaccine 12:299–306.
  • Audran, R., Men, Y., Johansen, P., Gander, B., and Corradin, G. 1998. Enhanced immunogenicity of microencapsulated tetanus toxoid using stabilizing agents. Pharm. Res. 15:1111–1116.
  • Cleland, J. L. 1999. Single immunization vaccines: Controlled release technol- ogy to mimic repeated immunization. Trends Biotech. 17:25–29.
  • Conway, B. R., Eyles, J. E., and Alpar, H. O. 1997. A comparative study on the immune response to antigen in PLA and PHB microspheres. J. Control. Rel. 49:1–9.
  • Diwan, M., Khar, R. K., and Talwar, G. P. 2001. Tetanus toxoid loaded preformed microspheres of crossd linked dextran. Vaccine 19:3853–3859.
  • Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., and Gilley, R. M. 1991. Biodegradable microsphere as vaccine delivery system. Mol. Immunol. 28:287–294.
  • Higaki, M., Azechi, Y., Takase, T., Igarashi, R., Nagahara, S., Sano, A., Fujiko, K., Nakagawa, N., Aizawa, C., and Mizushima, Y. 2001. Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid. Vaccine 19:3091–3096.
  • Hanes, J., Cleland, J. L., and Langer, R. 1997. New advances in microspheres based single dose vaccine. Adv. Drug Del. Rev. 28:97–119.
  • Johansen, P., Merkle, H. P., Corradin, G., and Gander, B. 2000. Revisiting PLA/PLGA microspheres: An analysis of their potential in parenteral vac- cination. Eur. J. Pharm. Biopharm. 50:129–146.
  • Johansen, P., Estevez, F., Zurbriggen, R., Merkle, H. P., Gluck, R., Corradin, G., and Gander, B. 2001. Towards the testing of a single-administration tetanus vaccine based on PLA/PLGA micropsheres. Vaccine 19:1047–1054.
  • Kersten, G. F. A., Donders, D., Akkermans, A., and Beuvery, E. C. 1996. Single shot with tetanus toxoid in biodegradable microsphere protects mice despite acid-induced denaturation of the antigen. Vaccine 14:1627–1632.
  • Katare, Y. K., and Panda, A. K. 2001. Effect of alum on in vitro release profile and immunogenicity of microencapsulated tetanus toxoid. Proc. Int. Symp. Control. Rel. Bioact. Mater. 28:1059–1060.
  • Kreuter, J., Leihl, E., Berg, U., Soliva, M., and Speiser, P. P. 1988. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants. Vaccine 6:253–256.
  • Lofthouse, S. 2002. Immunological aspects of controlled antigen delivery. Adv. Drug Del. Revi. 54:863–887.
  • Men, Y., Thomasin, C., Merkle, H. P., Gander, B., and Corradin G. 1995. A single administration of tetanus toxoid in biodegradable microspheres elicit T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine 13:683–689.
  • O’Hagan, D. T., Singh, M., and Gupta, R. K. 1998. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled release vaccine. Adv. Drug Del. Revi. 32:225–246.
  • O’Hagan, D. T., MacKichan, M. L., and Singh, M. 2001. Recent developments in adjuvants for vaccine against infectious disease. Biomol. Eng. 18:69–85.
  • Raghuvanshi, R. S., Goyal, S., Om., and Panda, A. K. 1998. Stabilization of dichloromethane induced protein denaturation during microencapsulation. Pharm. Devel. Tech 3:269–276.
  • Raghuvanshi, R. S., Om., and Panda, A. K. 2001. Formulation and char- acterization of immmunoreactive tetanus toxoid biodegradable polymer par- ticles. Drug Del. 8:99–106.
  • Raghuvanshi, R. S., Katare, Y. K., Lalwani, K., Ali, M., and Panda, A. K. 2002. Improved immunogenicity of polymer entrapped TT particles with adjuvants. Int. J. Pharm. 245:109–121.
  • Seferian, P. G., and Martinez, M. L. 2001. Immune stimulating activity of two new chitosan containing adjuvant formulation. Vaccine 19:661–668.
  • Singh, M., Li, X. M., Wang, H., McGhee, J. P., Zamb, T., Koff, W., Wang, C. Y., and O’Hagan, D. T. 1998. Controlled release of microparticles as single dose diptheria toxoid vaccine: Immunogenicity in small animal model. Vaccine 16:346–352.
  • Shi, L., Caufield, M. J., Chern, R. T., Wilson, R. A., Sanyal, G., and Volkin, D. V. 2002. Pharmaceutical and immunological evaluation of single shot hepatitis B vaccine formulated with PLGA microspheres. J. Pharm. Sci. 91:1019–1035.
  • Tobio, M., Schwendeman, S. P., Guy, Y., McIver, J., and Alonso, M. J. 2000. Improved immunogenicity of a core coated tetanus toxoid delivery system. Vaccine 18:618–622.
  • Walker, K. B., Xing, D. K., Sesardic, D., and Corbel, J. M. 1998. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide micro- spheres. Devel. Biol. Standard 92:259–267.
  • Weert, van de M., Hennink, W. E., and Jiskoot, W. 2000. Protein instability in poly (lactic-co-glycolic acid) microparticles. Pharm. Res. 17:1159–1167.
  • Zhu, K. J., Jiang, H. L., Du, X. Y., Wang, J., Xu, W. X., and Liu, S. F. 2001. Preparation and characterization of hCG loaded polylactide or polylactide- co-glycolide microsphere using a modified water–in-oil-in-water emulsion solvent evaporation techniques. J. Microencap. 18:247–260.
  • Zhu, G., Mallery, S. R., and Schwendenman, S. P. 2000. Stabilization of pro- teins encapsulated in injectable poly (lactide-co-glycolide). Nature Biotechn. 18:52–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.